A child you’ll never meet needs you

Angelman syndrome is a rare neurogenetic disorder that impacts approximately one in 15,000 people, robbing speech, balance, sleep, and the simple joy of independence. There is currently no cure today, but there is hope.

Scientists believe Angelman syndrome is curable.

This belief isn't wishful thinking. It's the fuel behind the Foundation for Angelman Syndrome Therapeutics (FAST)-- the largest non-governmental funder of Angelman syndrome research in the world.

We are not waiting for breakthroughs. We are building them.

Our pipeline is brimming with promising therapeutics-- from gene therapies to next-gen interventions—that could restore communication, independence, and a future full of firsts. Our mission is to deliver safe, life-changing treatments to patients and families as quickly as possible.

We will not stop until every individual living with Angelman syndrome can speak their first word, take their first unassisted step, and dream without limits.

But science this bold doesn't fund itself.
We need you.

Join FAST to help find a cure for Angelman syndrome.